CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing a minimally invasive cardiac implant to treat Persistent Atrial Fibrillation. The implant electrically isolates the Left Atrial Appendage, addressing both stroke and arrhythmia risks in a single procedure, thus improving patient outcomes and reducing healthcare costs.
Atrial Fibrillation (AF) is an irregular heartbeat caused by abnormal electrical activity in the heart, that can lead to blood clots with high risk of stroke and heart failure.
There are 10.7 million AF patients across Europe and the US, 3.6 million are classified as having Persistent AF (PAF), they are highly symptomatic and medication resistant.
Surgical electrical therapy (catheter ablation) destroys heart tissue causing the abnormal electrical pulses.
For PAF patients, this works only 30% of…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Israel, Rosh Haayin
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
TELEFLEX MEDICAL EUROPE LIMITED
Ireland, Athlone Co. Westmeath
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Ireland, Cork
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Czechia, Praha
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
